Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Patient Transitioning From Exubera®

It looks like they 're 4 and a half years into this 6 year test.I'm not sure why they verified it now but...

Patient Transitioning From Exubera® (Insulin Human [rDNA Origin]) Inhalation Powder to Technosphere® Insulin (Insulin Human [rDNA Origin]) Inhalation Powder

Verified by: Mannkind Corporation, February 2013

First Received: February 19, 2013 | Last Updated: February 22, 2013

Phase: Phase 3 | Start Date: October 2008

Overall Status: Active, not recruiting | Estimated Enrollment: 16

http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01798914

Share
New Message
Please login to post a reply